Modification of macrophage function and effects on atherosclerosis

Current Opinion in Lipidology

Volumn 7, Issue 5, 1996, Pages 320-323

  Murakami, Toru ^a   Yamada, Nobuhiro ^b  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; COLONY STIMULATING FACTOR 1;

ARTERY WALL; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL MATURATION; CELL TRANSFORMATION; FOAM CELL; GENE EXPRESSION; HUMAN; INTIMA; MACROPHAGE FUNCTION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR GENE; SHORT SURVEY; VASCULAR SMOOTH MUSCLE;

EID: 0029805968     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199610000-00010     Document Type: Short Survey

References (24)

1. Inoue I, Inaba T, Motoyoshi K, Harada K, Shimano H, Kawamura M, Gotoda T, Oka T, Shiomi M, Watanabe Y et al.: Macrophage colony-stimulating factor prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Atherosclerosis 1992, 93:245-254.
2. Inaba T, Shimano H, Gotoda T, Shimada M, Kawamura M, Yazaki Y, Yamada N: Macrophage colony-stimulating factor regulates both activities of neutral and acidic cholesteryl ester hydrolases in human monocyte-derived macrophages. J Clin Invest 1993, 92:479-485.
3. Yancey PG, St Clair R: Mechanism of the defect in cholesterol ester clearance from macrophages of atherosclerosis-susceptible White Carneau pigeons. J Lipid Res 1994, 35:2114-2129.
4. Ishii I, Kimuro T, Saito Y, Hirose S: Cholesterol metabolism in monocyte-derived macrophages from macrophage colony-stimulating factor administered rabbits. Biochim Biophys Acta 1994, 1254:51-55.
5. Schub RG, Bree MP, Hayes LL, Rudd MA, Rabbani LR, Loscalzo J, Clinton SK: Recombinant human macrophage colony-stimulating factor reduces plasma cholesterol and carrageena granuloma foam cell formation in Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb 1994, 14:70-76.
6. Ishibashi T, Yokoyama K, Shindo J, Hamazaki Y, Endo Y, Sato T, Takahashi S, Kawarabayasu Y, Shiomi M, Yamamoto T, Maruyama Y: Potent cholesterol-lowering effect by human granulocyte-macrophage colony-stimulating factor in rabbits. Arterioscler Thromb 1994, 14:1534-1541.
7. Smith JD, Trogan E, Ginsberg M, Grigaux C, Tian J, Miyata M: Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci U S A 1995, 92:8264-8268.
8. Shimano H, Ohsuga J, Shimada M, Namba Y, Gotoda T, Harada K, Katsuki M, Yazaki Y, Yamada N: Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall. J Clin Invest 1995, 95:469-476. To show the direct effect of apolipoprotein E on atherogenesis in the vascular wall, transgenic mice expressing human apolipoprotein E under control of the H2 Ld promoter were established. Transgenic mice with high expression of the human apolipoprotein E in the arterial wall demonstrated reduction in the formation of fatty streak lesions through enhanced cholesterol efflux from the aortic wall into plasma.
9. Boisvert WA, Spangenberg J, Curtiss LK: Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation. J Clin Invest 1995, 96:1118-1124. To study the role of apolipoprotein E on plasma cholesterol metabolism, bone marrow transplantation was performed on apolipoprotein E deficient mice with wild-type mouse bone marrow cells. The results demonstrated an important contribution of macrophage-derived apolipoprotein E both in reducing plasma cholesterol levels and in preventing the progression of atherosclerosis.
10. Roselaar SE, Schonfeld G, Daugherty A: Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity. J Clin Invest 1995, 96:1389-1395.
11. Keidar S, Kaplan M, Hoffman A, Aviram M: Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins. Atherosclerosis 1995, 115:201-215.
12. Kowala MC, Rose PM, Stein PD, Goller N, Recce R, Beyer S, Valentine M, Barton D, Durham SK: Selective blockade of the endothelin subtype A receptor decreases early atherosclerosis in hamsters fed cholesterol. Am J Pathol 1995, 146:819-826.
13. Galis ZS, Sukhova GK, Kranzhofer R, Clark S, Libby P: Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci U S A 1995, 92:402-426. The role of lipid-laden macrophages in the process of plaque/rupture was studied from the aspect of metalloproteinases. Production of metalloproteinases was demonstrated in macrophages isolated from aortic lesions, suggesting significant involvement in the atherosclerotic process.
14. Lupu F, Heim DA, Bachmann F, Hurni M, Kakkar W, Kruithof EK: Plasminogen activator expression in human atherosclerotic lesions. Anerioscler Thromb Vasc Biol 1995, 15:1444-1455.
15. Lundgren CH, Sawa H, Sobel BE, Fujii S: Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy. Circulation 1994, 90:1927-1934.
16. Kume S, Takeya M, Mori T, Araki N, Suzuki H, Horiuchi S, Kodama T, Miyauchi Y, Takahashi K: Immunohistochemical and ultrastructual detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody. Am J Pathol 1995, 147:654-667.
17. Araki N, Higashi T, Mori T, Shibayama R, Kawabe Y, Kodama T, Takahashi K, Shichiri M, Horiuchi S: Macrophage scavenger receptor mediates the endocytic uptake and degradation of advanced glycation end products of Maillard reaction. Eur J Biochem 1995, 230:408-415.
18. Li H, Freeman MW, Libby P: Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. J Clin Invest 1995, 95:122-133.
19. Geng YJ, Hansson GK: Interferon-y inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J Clin Invest 1992, 89:1322-1330.
20. Gong Q, Pitas RE: Synergistic effects of growth factors on the regulation of smooth muscle cell scavenger receptor activity. J Biol Chem 1995, 270:21672-21678.
21. Inaba T, Gotoda T, Harada K, Shimada M, Ohsuga J, Ishibashi S, Yazaki Y, Yamada N: Induction of sustained expression of proto-oncogene c-fms by platelet-derived growth factor, epidermal growth factor, and basic fibroblast growth factor, and its suppression by interferon-y and macrophage colony-stimulating factor in human aortic medial smooth muscle cells. J Clin Invest 1995, 95:1133-1139.
22. Zhang DE, Hetherington CJ, Chen HM, Tenen DJ: The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor. Mol Cell Biol 1994, 14:373-381.
23. Moulton KS, Semple K, Wu H, Glass CK: Cell-specific expression of the macrophage scavenger receptor gene is dependent on PU.1 and a composite AP-1/ets motif. Mol Cell Biol 1994, 14:4408-4418.
24. Inaba T, Gotoda T, Ishibashi S, Harada K, Ohsuga J, Ohashi K, Yazaki Y, Yamada N: Transcription factor PU.1 mediates the induction of c-fms in vascular smooth muscle cells: a mechanism for phenotypical change to phagocytic cells. Mol Cell Biol 1996, 16:2264-2273. The transcriptional regulation of the phenotypic conversion of vascular smooth muscle cells in atherosclerosis was studied. Deletion analysis of the c-fms promoter revealed that a region including a binding site for transcription factor PU.1 was required for transcriptional activity in human aortic medial smooth muscle cells.